Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2026-03-30 00:00:00 ET · period of report 2026-03-26 · accession 0001493152-26-013574 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-30 | 2026-03-26 | IMDX | James Andrea S. | CFO | M - OptEx | — | +28.3K | 217.4K | +15% | — |
| D | 2026-03-30 | 2026-03-26 | IMDX | James Andrea S. | CFO | F - Tax | $4.11 | -11.3K | 206.1K | -5% | -$46.4K |
| D | 2026-03-30 | 2026-03-26 | IMDX | James Andrea S. | CFO | M - OptEx | $0.00 | -28.3K | 84.9K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-26 | M | A | 28,302 | — | 217,358 | D | — | — | (F1) Represents vesting of restricted stock units ("RSUs") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs vested on the one-year anniversary of the effective date of grant. |
| 2 | Common | Common Stock | 2026-03-26 | F | D | 11,298 | $4.11 | 206,060 | D | — | — | (F2) The reported disposition reflects shares withheld by the Company to cover required tax withholding obligations upon the vesting of the RSUs. The reporting person did not sell any shares. |
| 3 | Derivative | Restricted Stock Units | 2026-03-26 | M | D | 28,302 | $0.00 | 84,905 | D | — · — to — | 28,302 Common Stock | (F3) Each RSU has a value equal to one share of common stock. 25% of the RSUs vested on March 26, 2026 and the remaining 75% will vest in equal installments on each of the second-, third- and fourth-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date. |